Total raised: $25M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.04.2025 | - | $25M | - |
Mentions in press and media 4
| Date | Title | Description |
| 08.04.2025 | Stramsen Biotech Secures $25 Million to Propel Plant-Based Medicine Forward | Stramsen Biotech is on the rise. The Houston-based company has secured a significant $25 million funding commitment from GEM Global Yield, a Luxembourg-based investment group. This financial boost is not just a number; it’s a launchpad. It ... |
| 08.04.2025 | Stramsen Biotech: $25 Million Funding Commitment Raised From GEM Global Yield | Stramsen Biotech (an emerging leader in plant-based biopharmaceutical industry) announced that it has signed a binding agreement with GEM Global Yield (GGY), part of GEM, a Luxembourg-based private alternative investment group as its Lead I... |
| 07.04.2025 | Stramsen Biotech Raises $25M in Funding | Stramsen Biotech, a Houston, TX-based plant-based biopharmaceutical company, raised $25M in funding. The round was led by GEM Global Yield LLC SCS, part of GEM. The company intends to use the funds to: Accelerate global expansion initiative... |
| - | Stramsen Biotech | “Home | Stramsen Biotech, Inc” |